Rapid Release Ripped Tabs TR By IDS Overview & Drug Interactions

Check For Interactions With Rapid Release Ripped Tabs TR

Supplement: Rapid Release Ripped Tabs TR by IDS

Rapid Release Ripped Tabs TR Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Rapid Release Ripped Tabs TR by IDS

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

There were no interactions found with Rapid Release Ripped Tabs TR. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.


Still looking for more information about Rapid Release Ripped Tabs TR interactions? Ask Dr. Brian Staiger about it by contacting him directly.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
2 Tablet(s)
Maximum serving Sizes:
2 Tablet(s)
Servings per container 30
UPC/BARCODE 675941001623

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Anabolic Amplifier Proprietary Blend
300 mg
Proprietary Blend --
Energy XT(TM) Proprietary Blend
425 mg
Proprietary Blend (Combination) --
Anabolic Cutter Blend
234 mg
Proprietary Blend (Combination) --

Other Ingredients:
Microcrystalline Cellulose
Dicalcium Phosphate
Croscarmellose Sodium
Stearic Acid
Magnesium Stearate
Silica
Film Coat
Forms
  • FD&C Yellow #5 Lake
  • FD&C Yellow #6 Lake
  • Hypromellose
  • Maltodextrin
  • Medium Chain Triglycerides
  • Polydextrose
  • Talc
  • Titanium Dioxide


Label Statments:


Precautions
- Women should not use this product if pregnant, nursing or lactating. If you are using birth control pills, please consult your physician before use.
- Not For Use By Minors
- Do Not Use If Seal Is Broken
- Keep Out Of Reach Of Children
- WARNING: Consult a physician before taking this or any dietary supplement. Men with a prostate condition or who are susceptible to prostate disease should consult with their physician before using this product.
- Not intended for use in persons under 18 years of age.
- Please consult a physician before use if you are taking prescription medications.
Suggested/Recommended/Usage/Directions
- Directions: Take two tablets prior to breakfast on both workout and non workout days. Best results when taken for four weeks consecutively with at least four weeks off.
FDA Disclaimer Statement
- The statements on this label have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
General Statements
- MADE IN USA
- ANABOLIC CUTTING AGENT
- FAT METABOLISM STIMULANT STRENGTH
Seals/Symbols
- Good Manufacturing Practices GMP
- IDS
FDA Statement of Identity
- DIETARY SUPPLEMENT
Brand IP Statement(s)
- IDS Ripped Tabs TR(TM) are specifically formulated to help reduce subcutaneous bodyfat while increasing lean defined muscle tissue when used with a high protein diet and proper strength training.

Brand Information

See all products by this brand

Distributed by
Name IDS
Street Address 5707 Dot Com Court, Suite 1079
City Oviedo
State FL
ZipCode 32765
Phone Number (888) 950-3373
Web Address www.idssports.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.